Diastolic dysfunction in spontaneous type 2 diabetes rhesus monkeys: A study using echocardiography and magnetic resonance imaging

BMC Cardiovascular Disorders

Volumn 15, Issue 1, 2015, Pages

  Qian, Can ^a,b   Gong, Li ^b   Yang, Zunyuan ^b   Chen, Wei ^c   Chen, Yushu ^c   Xu, Ziqian ^c   Wu, Bing ^c   Tang, Chungui ^d   Gao, Fabao ^c   Zeng, Wen ^a,b  

^a Sichuan Industrial Institute of Antibiotics   (China)

^b Sichuan PriMed Shines Bio Tech Co Ltd   (China)

^c SICHUAN UNIVERSITY   (China)

^d Yaan People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CASPASE 3; GLUCOSE; HEMOGLOBIN A1C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE DURATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART MUSCLE INJURY; M MODE ECHOCARDIOGRAPHY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; TISSUE DOPPLER IMAGING; ULTRASOUND SCANNER; ANIMAL; CINE MAGNETIC RESONANCE IMAGING; DIAGNOSTIC IMAGING; DIASTOLIC HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; PATHOPHYSIOLOGY; PROCEDURES; PULSED DOPPLER ECHOCARDIOGRAPHY;

ANIMALS; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY, DOPPLER, PULSED; HEART FAILURE, DIASTOLIC; HUMANS; MACACA MULATTA; MAGNETIC RESONANCE IMAGING, CINE; MALE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84933505342     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/s12872-015-0046-9     Document Type: Article

References (55)

1. American Heart Association. Cardiovascular Disease & Diabetes accessed at http://www.heart.org/ . 2013.
2. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. Oct 15 2013;62(16):e147-239.
3. Tziakas DN, Chalikias GK, Kaski JC. Epidemiology of the diabetic heart. Coron Artery Dis. 2005;16 Suppl 1:S3-s10.
4. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115(25):3213-23.
5. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004;25(4):543-67.
6. Hayat SA, Patel B, Khattar RS, Malik RA. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci. 2004;107(6):539-58.
7. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil J-G. Diastolic Dysfunction in Normotensive Men with Well-Controlled Type 2 Diabetes: Importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 2001;24(1):5-10.
8. Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol. 2001;87(3):320-3.
9. Raev DC. Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients. Diabetes Care. 1994;17(7):633-9.
10. Candido R, Forbes JM, Thomas MC, et al. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res. 2003;92(7):785-92.
11. Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ. Hyperglycemia-induced apoptosis in mouse myocardium mitochondrial cytochrome c-mediated caspase-3 activation pathway. Diabetes. 2002;51(6):1938-48.
12. Sadayappan S, Gulick J, Osinska H, et al. Cardiac myosin-binding protein-C phosphorylation and cardiac function. Circ Res. 2005;97(11):1156-63.
13. Aasum E, Hafstad AD, Severson DL, Larsen TS. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes. 2003;52(2):434-41.
14. Rodrigues B, McNeill JH. Cardiac dysfunction in isolated perfused hearts from spontaneously diabetic BB rats. Can J Physiol Pharmacol. 1990;68(4):514-8.
15. Loganathan R, Bilgen M, Al-Hafez B, Alenezy MD, Smirnova IV. Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging. Cardiovasc Diabetol. 2006;5(1):7.
16. Kralik PM, Ye G, Metreveli NS, Shen X, Epstein PN. Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes. Cardiovasc Toxicol. 2005;5(3):285-92.
17. Yu X, Tesiram YA, Towner RA, et al. Early myocardial dysfunction in streptozotocin-induced diabetic mice: a study using in vivo magnetic resonance imaging (MRI). Cardiovasc Diabetol. 2007;6(1):6.
18. Hoit BD, Castro C, Bultron G, Knight S, Matlib MA. Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats. J Card Fail. 1999;5(4):324-33.
19. Gibbs RA, Rogers J, Katze MG, et al. Evolutionary and biomedical insights from the rhesus macaque genome. Science. 2007;316(5822):222-34.
20. Ortmeyer HK, Bodkin N, Hansen BC. Insulin-mediated glycogen synthase activity in muscle of spontaneously insulin-resistant and diabetic rhesus monkeys. Am J Physiol Regul Integr Comp Physiol. 1993;265(3):R552-8.
21. Hansen B, Bodkin N. Beta-cell hyperresponsiveness: earliest event in development of diabetes in monkeys. Am J Physiol Regul Integr Comp Physiol. 1990;259(3):R612-7.
22. Hansen B, Bodkin N. Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey. Diabetologia. 1986;29(10):713-9.
23. Gong L, Zeng W, Yang Z, et al. Comparison of the Clinical Manifestations of Type 2 Diabetes Mellitus Between Rhesus Monkey (Macaca mulatta lasiotis) and Human Being. Pancreas. 2013;42(3):537-42.
24. Hansen BC. Investigation and treatment of type 2 diabetes in nonhuman primates. Methods Mol Biol. 2012;933:177-85.
25. Wagner JD, Kavanagh K, Ward GM, Auerbach BJ, Harwood HJ, Kaplan JR. Old world nonhuman primate models of type 2 diabetes mellitus. ILAR J. 2006;47(3):259-71.
26. Zeng W, Wen X, Gong L, et al. Establishment and ultrasound characteristics of atherosclerosis in rhesus monkey. Biomed Eng Online. 2015;14 Suppl 1:S13.
27. Voutilainen S, Kupari M, Hippelainen M, Karppinen K, Ventila M. Circadian variation of left ventricular diastolic function in healthy people. Heart. 1996;75(1):35-9.
28. Zeng W, Cheng A-c, Chen Z-l, et al. In vivo assessment of mitochondrial toxicity of metacavir in rhesus monkeys after three months of intravenous administration. Acta Pharmacol Sin. 2009;30(12):1666-73.
29. Semeniuk LM, Kryski AJ, Severson DL. Echocardiographic assessment of cardiac function in diabeticdb/db and transgenic db/db-hGLUT4 mice. Am J Physiol Heart Circ Physiol. 2002;283(3):H976-82.
30. Moreo A, Ambrosio G, De Chiara B, et al. Influence of myocardial fibrosis on left ventricular diastolic function noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging. 2009;2(6):437-43.
31. Sohn D-W, Chai I-H, Lee D-J, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol. 1997;30(2):474-80.
32. Paulus WJ, Tschöpe C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28(20):2539-50.
33. Hirai J, Ueda K, Takegoshi T, Mabuchi H. Effects of metabolic control on ventricular function in type 2 diabetic patients. Intern Med. 1992;31(6):725-30.
34. Boyer JK, Thanigaraj S, Schechtman KB, Pérez JE. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol. 2004;93(7):870-5.
35. Khan JN, Wilmot EG, Leggate M, et al. Subclinical diastolic dysfunction in young adults with Type 2 diabetes mellitus: a multiparametric contrast-enhanced cardiovascular magnetic resonance pilot study assessing potential mechanisms. European Heart Journal Cardiovascular Imaging. Nov 2014;15(11):1263-1269.
36. Korcarz CE, Padrid PA, Shroff SG, Weinert L, Lang RM. Doppler echocardiographic reference values for healthy rhesus monkeys under ketamine hydrochloride sedation. J Med Primatol. 1997;26(6):287-98.
37. Tang HL, Wang LL, Cheng G, Wang L, Li S. Evaluation of the cardiovascular function of older adult rhesus monkeys by ultrasonography. J Med Primatol. 2008;37(2):101-8.
38. Sleeper MM, Gaughan JM, Gleason CR, Burkett DE. Echocardiographic reference ranges for sedated healthy cynomolgus monkeys (Macaca fascicularis). Am Assoc Lab Anim Sci. 2008;47(1):22.
39. Keenan CM, Vidal JD. Standard morphologic evaluation of the heart in the laboratory dog and monkey. Toxicol Pathol. 2006;34(1):67-74.
40. Maya L, Villarreal FJ. Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis. J Mol Cell Cardiol. 2010;48(3):524-9.
41. Danzmann LC, Bodanese LC, Köhler I, Torres MR. Left atrioventricular remodeling in the assessment of the left ventricle diastolic function in patients with heart failure: a review of the currently studied echocardiographic variables. Cardiovasc Ultrasound. 2008;6(1):56.
42. Galderisi M. Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol. 2006;48(8):1548-51.
43. Farias CA, Rodriguez L, Garcia MJ, Sun JP, Klein AL, Thomas JD. Assessment of diastolic function by tissue Doppler echocardiography: comparison with standard transmitral and pulmonary venous flow. J Am Soc Echocardiogr. 1999;12(8):609-17.
44. From AM, Scott CG, Chen HH. The Development of Heart Failure in Patients With Diabetes Mellitus and Pre-Clinical Diastolic DysfunctionA Population-Based Study. J Am Coll Cardiol. 2010;55(4):300-5.
45. Bonito P, Moio N, Cavuto L, et al. Early detection of diabetic cardiomyopathy: usefulness of tissue Doppler imaging. Diabet Med. 2005;22(12):1720-5.
46. Ernande L, Bergerot C, Rietzschel ER, et al. Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiogr. 2011;24(11):1268-75. e1261.
47. Sechtem U, Pflugfelder P, Higgins CB. Quantification of cardiac function by conventional and cine magnetic resonance imaging. Cardiovasc Intervent Radiol. 1987;10(6):365-73.
48. Mihm MJ, Seifert JL, Coyle CM, Bauer JA. Diabetes related cardiomyopathy time dependent echocardiographic evaluation in an experimental rat model. Life Sci. 2001;69(5):527-42.
49. Joffe II, Travers KE, Perreault-Micale CL, et al. Abnormal cardiac function in the streptozotocin-induced, non-insulin-dependent diabetic rat: Noninvasive assessment with Doppler echocardiography and contribution of the nitric oxide pathway. J Am Coll Cardiol. 1999;34(7):2111-9.
50. Akula A, Kota M, Gopisetty S, et al. Biochemical, histological and echocardiographic changes during experimental cardiomyopathy in STZ-induced diabetic rats. Pharmacol Res. 2003;48(5):429-35.
51. Factor SM, Bhan R, Minase T, Wolinsky H, Sonnenblick EH. Hypertensive-diabetic cardiomyopathy in the rat: an experimental model of human disease. Am J Pathol. 1981;102(2):219.
52. Factor SM, Minase T, Sonnenblick EH. Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. Am Heart J. 1980;99(4):446-58.
53. Kuethe F, Sigusch H, Bornstein S, Hilbig K, Kamvissi V, Figulla H. Apoptosis in patients with dilated cardiomyopathy and diabetes: a feature of diabetic cardiomyopathy? Horm Metab Res. 2007;39(09):672-6.
54. Chung J, Jeong E-M, Go Y, et al. Mitochondria-targeted antioxidant ameliorates diet-induced diabetes and diastolic dysfunction. Journal of the American College of Cardiology. 2013;61(10):E597.
55. Shen X, Zheng S, Metreveli NS, Epstein PN. Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes. 2006;55(3):798-805.